Director Kaplan Myron made one open market purchase of CorMedix Inc. ($CRMD) shares in the last year, totaling $275,500. His most recent buy occurred on October 23, 2025. This places him in 1,228th position among 4,983 insiders by purchase value, compared to the average of $1.46 million across about 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | CorMedix Inc. | $CRMD | Kaplan Myron | Director | A | Common Stock | 30453 | $0.00 | 261,487.0000 | 80,308 | 13.18% | 37.92% |
| Oct. 23, 2025 | CorMedix Inc. | $CRMD | Kaplan Myron | Director | P | Common Stock | 25000 | $11.02 | 231,034.0000 | 86,214,170 | 12.13% | 0.03% |
| Jan. 17, 2025 | CorMedix Inc. | $CRMD | Kaplan Myron | Director | A | Common Stock | 25000 | $0.00 | 206,034.0000 | 58,872 | 13.81% | 42.47% |
| March 5, 2024 | CorMedix Inc. | $CRMD | Kaplan Myron | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |